Latest news with #NuclearMagneticResonance
Time Business News
24-06-2025
- Science
- Time Business News
Utilization and Driving Factors in the Molecular Spectroscopy Market
The matter (molecules) and electromagnetic radiations has active interaction in molecular spectroscopy that are able to generate an absorption pattern or spectrum. This particular type of spectroscopy is utilized to learn more about a compound's composition or structure. The molecular spectroscopy market is growing rapidly with factors such as growing need around various industries such as food safety, environmental monitoring, pharmaceuticals and research with enhancing precision and portability of instruments with advancement in technology. Major growth aspects tailor around the tissue regeneration, embryonic development, and immune responses. Therapeutically, given aspects are more focused on wound healing, cancer treatment and regenerative medicine. Key Growth Drivers and Opportunities Molecular Spectroscopy in Pharmaceutical: Molecular spectroscopy analysis has an important role in enhancing the domain of pharmaceuticals for examining drug crystalline structures, drug identity and purity, antibiotics patent, active ingredients and excipients interactions and other aspects. Spectrophotometry is frequently utilized in bioanalysis, stability testing, impurity profiling, dissolution investigations, and pharmaceutical tests. Environmental Testing and Food Safety: Molecular spectroscopy has ability to detect chemical compositions, toxins and contaminants without any alteration in the sample which makes it highly valuable in diagnostics. It is extremely advantageous for regulatory compliance, which verifies that items meet safety regulations. Its high adoption in field-based assessments and remote sensing is due to portability and rapid response. Challenges The molecular spectroscopy falls short for determining molecule's structure completely although it is useful for molecular characteristics. Techniques including UV-Vis and IR spectroscopy may be utilized to determine functional groups and collect data on electronic transitions or vibrational modes. They cannot provide comprehensive and important details regarding atom connectivity or a molecule's three-dimensional configuration. Innovation and Expansion Thermo Fisher with Two Groundbreaking Modern Spectrometers In June 2025, Thermo Fisher introduced two cutting-edge Orbitrap mass spectrometers namely Orbitrap Astral Zoom MS for 35% faster scanning, 40% higher throughput, and 50% more multiplexing—enabling over 300 proteomes/day and Orbitrap Excedion Pro MS for EASY‑ETD fragmentation for deeper proteomics coverage used in critical in biologics characterization. Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR In April 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the 'Multi-Talent' configuration. This novel Fourier 80 'Multi-Talent' system represents a major advancement in permanent magnet-based FT-NMR technology, as its unique, next-generation capabilities meet the evolving needs of academic researchers and industry scientists with dramatically enhanced versatility in benchtop FT-NMR multinuclear analysis. HORIBA Provides Contribution for Vaccine and Protein Analysis In March 2025, the HORIBA introduced Veloci which is a biopharma analyzer A-TEEM (absorbance/transmittance with fluorescence EEM), that enables label-free molecular finger prints for vaccine and protein analysis. JASCO Profits Off with its New Launch of Fluorescence Spectrophotometers In March 2021, fluorescence spectrophotometers (FP-8050 Series) which is completely new range was launched by JASCO. Given strategic launch helped the company to drive its revenue by enhancing their product portfolio. Real-time infrared spectroscopy tracks organocatalyst action Several researchers at University of Amsterdam and HFML‑FELIX used free-electron laser-based IR spectroscopy along with quantum-chemical modeling to observe the structure and binding dynamics of a thiourea organocatalyst that interacts with nitroolefin reactants. Eventually allowing the 'freezing out' reactive intermediates that makes way for rational catalyst design. Inventive Sparks, Expanding Markets The key contributors in Molecular Spectroscopy domain includes Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QUANTUM ANALYTICS, PerkinElmer Inc., Shimadzu Corporation, and others are greatly emphasizing on expanding applications into new areas including biomedicine and nanotechnology, integrating advanced data analysis capabilities, and concentrating on producing extremely delicate and portable devices. The goal of this advancement is to boost the affordability of molecular spectroscopy for on-site environmental monitoring and point-of-care diagnostics. Also, collaborations with academics in AI and machine learning have stepped up the establishment of intelligent, self-governing analytical systems. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
Cision Canada
13-06-2025
- Business
- Cision Canada
Nanalysis Announces Closing of Fully Subscribed Note Offering
CALGARY, AB, /CNW/ - Nanalysis Scientific Corp. (the " Company" or " Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has closed its previously-announced offering of 12% unsecured promissory notes (the " Notes") for aggregate gross proceeds of $2,000,000 (the " Offering"). The Notes were issued to arm's length third-party investors (the " Lenders"). The Notes mature on June 13, 2027, and bear simple interest at a rate of 12% per annum, payable annually within 30 days of the first and second anniversary date of the Notes. At the Company's option and subject to TSX Venture Exchange (" TSXV") approval, the interest may be paid in cash or common shares of the Company. The Company intends to use the net proceeds from the Offering for general corporate purposes and to support ongoing business operations. In connection with the Notes, the Company has issued 1,600,000 common shares of the Company (the " Bonus Shares") to the Lenders. The Bonus Shares represent a value equal to 20% of the principal amount of the Notes, calculated based on the Market Price (as defined by the TSXV) of $0.25 per Bonus Share, which was the closing price of the Company's common shares on June 5, 2025 prior to the announcement of the Offering. The Bonus Shares are subject to a four month hold period, expiring October 13, 2025, in accordance with applicable securities legislation. About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.
Yahoo
13-06-2025
- Business
- Yahoo
Nanalysis Announces Closing of Fully Subscribed Note Offering
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, June 13, 2025 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has closed its previously-announced offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $2,000,000 (the "Offering"). The Notes were issued to arm's length third-party investors (the "Lenders"). The Notes mature on June 13, 2027, and bear simple interest at a rate of 12% per annum, payable annually within 30 days of the first and second anniversary date of the Notes. At the Company's option and subject to TSX Venture Exchange ("TSXV") approval, the interest may be paid in cash or common shares of the Company. The Company intends to use the net proceeds from the Offering for general corporate purposes and to support ongoing business operations. In connection with the Notes, the Company has issued 1,600,000 common shares of the Company (the "Bonus Shares") to the Lenders. The Bonus Shares represent a value equal to 20% of the principal amount of the Notes, calculated based on the Market Price (as defined by the TSXV) of $0.25 per Bonus Share, which was the closing price of the Company's common shares on June 5, 2025 prior to the announcement of the Offering. The Bonus Shares are subject to a four month hold period, expiring October 13, 2025, in accordance with applicable securities legislation. About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. SOURCE Nanalysis Scientific Corp. View original content to download multimedia:
Cision Canada
06-06-2025
- Business
- Cision Canada
Nanalysis Announces Fully Subscribed $2 Million Note Offering
CALGARY, AB, June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the " Company" or " Nanalysis") (TSXV: NSCI, , FRA: 1N1), is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the " Notes") for aggregate gross proceeds of $2,000,000 (the " Offering") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common shares to subscribers. These shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable securities laws. Closing of the Offering is scheduled to occur on or about June 11, 2025, and remains subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including TSX Venture Exchange (" TSXV") acceptance. For further information regarding the Offering, please refer to the Company's news release dated June 6, 2025, available on SEDAR+ at Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: closing of the Offering; TSXV approval of the Notes and issuance of Bonus Shares; the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval; the Company's payment of finder's fees in connection with the Offering; and investor participation in the Offering. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.
Yahoo
06-06-2025
- Business
- Yahoo
Nanalysis Announces Fully Subscribed $2 Million Note Offering
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $2,000,000 (the "Offering") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common shares to subscribers. These shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable securities laws. Closing of the Offering is scheduled to occur on or about June 11, 2025, and remains subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including TSX Venture Exchange ("TSXV") acceptance. For further information regarding the Offering, please refer to the Company's news release dated June 6, 2025, available on SEDAR+ at About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: closing of the Offering; TSXV approval of the Notes and issuance of Bonus Shares; the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval; the Company's payment of finder's fees in connection with the Offering; and investor participation in the Offering. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. SOURCE Nanalysis Scientific Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
